IL-12 mainly promotes the differentiation of Th1 cells and the production of interferon-γ, while IL-23 stimulates the expansion of Th17 cells and the secretion of pro-inflammatory cytokines, processes that collectively drive the inflammatory progression of IBD. Here, IL23A is linked to inflammatory bowel disease.